{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["104(7)"],"submitter":["Cheung LC"],"journal":["Haematologica"],"pagination":["e300-e303"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6601077"],"repository":["biostudies-literature"],"pubmed_title":["Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia."],"pmcid":["PMC6601077"],"pubmed_authors":["Ford J","Lock RB","Oommen J","Cheung LC","Kees UR","Hughes AM","Ferrari E","Kotecha RS","Cruickshank MN","Singh S","Malinge S","Chua GA"],"additional_accession":[]},"is_claimable":false,"name":"Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Jul","modification":"2025-04-22T20:25:06.351Z","creation":"2025-04-06T03:06:42.847Z"},"accession":"S-EPMC6601077","cross_references":{"pubmed":["30679330"],"doi":["10.3324/haematol.2018.192906"]}}